We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urinary Analysis in Early Pregnancy Predicts Likelihood of Preterm Birth

By LabMedica International staff writers
Posted on 24 Jul 2014
Analysis of metabolites in the urine during the early stages of pregnancy was found to be an effective approach for predicting the likelihood of a preterm birth.

Preterm birth (PB) and fetal growth restriction (FGR) convey high risk of infant mortality and morbidity, as well as increasing the chance of developing chronic disease in later life. More...
Biomarkers identified early in pregnancy could predict poor birth outcomes and aid in their prevention and management.

Investigators at Imperial College London (United Kingdom) and the University of Crete (Greece) used proton nuclear magnetic resonance spectroscopy to analyze metabolites in urine samples obtained at the first ultrasound appointment from 438 pregnant women in the Rhea cohort. The Rhea cohort is a large population case-control mother-child study that started in Crete in 2007.

Results revealed that elevated urinary levels of lysine were associated with spontaneous premature birth. Decreased levels of acetate, formate, tyrosine, and trimethylamine were associated with poor fetal development. Women with decreased levels of these urine metabolites also showed signs of an increased risk of diabetes, such as higher blood insulin. Increased levels of an N-acetylated glycoprotein were significantly associated with induced preterm birth (IPB) in overweight and obese women only.

Senior author Dr. Hector Keun, senior lecturer in biological chemistry at Imperial College London, said, "While we know that metabolism in the mother changes substantially during pregnancy to help supply the growing fetus with nutrients, we were surprised to see so early in pregnancy a link between metabolites that we could easily detect in a urine sample and low birth weight. Our findings imply that it could be possible to improve the identification of women at higher risk of delivering smaller babies or premature delivery using noninvasive metabolic profiling technology early in pregnancy. Future investigation of the factors that produce the molecules associated with these pregnancy outcomes should improve our understanding of the genetic and environmental factors that influence restricted fetal growth and thus help us to reduce the likelihood of these events. We will also go on to test if exposure to these metabolites during pregnancy has a lasting impact on child development after birth."

The urine metabolites study was published in the July 11, 2014, online edition of the journal BMC Medicine.


Related Links:

Imperial College London

University of Crete




Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
New
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.